VNVictor Neira

Victor Neira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Victor Neira has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Public Information-Seeking About Catheter Ablation for Atrial Fibrillation and Supraventricular Tachycardia: Cross-sectional Content Analysis (Preprint)

    by Sarvesh Kumarsingh Ramlochun, Siddharth Gandhi, Isha Gill, Michael Balas, Matthew Hanson, Victor M. Neira Vidal

    BACKGROUND Patients increasingly seek online information about catheter ablation for atrial fibrillation (AF) and supraventricular tachycardia (SVT), yet the types of patient-facing questions encountered, and the transparency of associated information sources remain poorly characterized. OBJECTIVE To characterize public questions related to AF and SVT catheter ablation using Google’s “People Also Ask” (PAA) feature and to evaluate transparency of linked websites. METHODS A cross-sectional analysis of Google PAA results was conducted using six standardized search terms related to AF and SVT ablation. The first 100 PAA questions per term were extracted (600 total; 300 AF, 300 SVT) along with linked webpages. Questions were independently classified using Rothwell’s framework (Fact, Value, Policy, Other) and thematic subclassifications. Websites were categorized by source type and scored using Journal of the American Medical Association (JAMA) benchmark criteria (0–4). RESULTS Overall question distributions were Fact 35%, Value 33%, Policy 31%, and Other 1%. Common themes included evaluation of the procedure (23%), indications/management (22%), restrictions (13%), technical details (11%), and risks/complications (9%). High-frequency queries emphasized recovery, activity restrictions, procedural risks, and expected outcomes. Website transparency was variable (mean JAMA score 2.92±1.08, n=600), with academic and commercial sources most frequently represented. CONCLUSIONS Public questions about AF and SVT ablation extend beyond procedural facts and reflect decision-oriented concerns. Patients appear to use online information to understand procedures, shape expectations, and support decision-making before clinical consultation. Recognizing common question patterns and variability in website transparency may help support structured, patient-centered counselling and shared decision-making.

  • Open Access

    Zero‐Fluoroscopy Radiofrequency Ablation of a Right Ventricular Outflow Tract PVC in a Patient With Situs Inversus Totalis: When Precision Matters

    by Eduardo Sanhueza, Matthew Hanson, Victor Neira, Sanoj Chacko, Andres Enriquez, Roji Oli, Mariana Saramago, Cengiz Burak

    Background: Congenital cardiac anomalies present unique challenges for adult cardiac electrophysiologists, particularly when attempting complex ablation procedures. Case Summary: We report the case of a 60‐year‐old male with situs inversus totalis who presented with symptomatic, high‐burden premature ventricular complexes (PVCs) refractory to medical therapy. Using reversed (mirror‐image) precordial lead placement, high‐definition 3D electroanatomic mapping, and intracardiac echocardiography, successful radiofrequency ablation was achieved using a completely zero‐fluoroscopy approach. Discussion: In patients with congenital cardiac anomalies, the applicability of zero‐fluoroscopy strategies is often limited because of their complex anatomy. Successful management requires in‐depth anatomical understanding and carefully adapted procedural techniques. This case highlights that even in the setting of significant anatomical variation, a systematic zero‐fluoroscopy approach can lead to effective and safe outcomes. Take‐Home Message: Zero‐fluoroscopy PVC radiofrequency ablation using high‐definition 3D mapping and intracardiac echocardiography is a feasible and safe approach, even in anatomically challenging cases such as situs inversus.

  • Stepwise Anatomical Approach to Ablation of Intramural Outflow Tract Ventricular Arrhythmias Guided by Septal Coronary Venous Mapping

    by Andres Enriquez, Haran Yogasundaram, Victor Neira, Gustavo Guandalini, Timothy Markman, Poojita Shivamurthy, Matthew Hyman, Balaram Hanumanthu, David Lin, Robert Schaller, et al.

    BACKGROUND: The intramural site of origin is a major cause of ablation failure of ventricular arrhythmias, and the optimal strategy is unclear. This study investigated the efficacy of a stepwise ablation approach for intramural outflow tract (OT) premature ventricular complexes (PVCs) guided by mapping of the septal coronary venous system. METHODS: Consecutive patients with OT PVCs were included, in whom an intramural origin was confirmed by demonstration of earliest activation in a septal coronary vein. Radiofrequency ablation was performed from the closest endocardial site in the left ventricular OT or right ventricular OT independent of the local activation time. If there was no suppression by endocardial ablation, then retrograde transvenous ethanol infusion with a single- or double-balloon technique was performed, targeting the earliest septal coronary vein. If venous anatomy was not suitable for ethanol ablation or if this failed, then bipolar ablation was performed. RESULTS: Sixty patients (age 61±12 years; 78% men) were included. The mean QRS duration of the PVC was 150.8±17.6 ms with a maximum deflection index of 0.51±0.11, and the most common ECG pattern was a left bundle branch block with inferior axis and V3 transition (63%), followed by a right bundle branch block with inferior axis and no transition (27%). Earliest ventricular activation (28.6±11.2 ms before QRS) was recorded in the left ventricular annular vein in 15 cases and a septal perforator vein in 45 cases. Acute PVC suppression at the end of the procedure was achieved in all cases. In 87% of cases (n=52), endocardial ablation from the endocardial left ventricular OT, right ventricular OT, or both was successful in eliminating the PVC. In the remaining 8 patients, the PVC was eliminated with ethanol infusion (n=7) and bipolar ablation (n=1). Complications included one case of pericardial effusion related to venous mapping. During follow-up (17±24 months), the PVC burden was reduced from 28±12% to 2.3±4.7%, and long-term success (≥80% burden reduction) was 88%. CONCLUSIONS: Most intramural OT PVCs can be successfully eliminated with endocardial ablation adjacent to the earliest intramural activation site. A high success rate is achieved when following a stepwise approach, with bailout ablation strategies required in a minority of cases.


  • Sequential Intracardiac Activation Time Mapping of Arrhythmias Without Fiducial Time References

    by Mohammad Hassan Shariat, Victor Neira, Damian P. Redfearn

    Sequential local activation time (LAT) mapping of intracardiac electrograms' activations requires a stable reference signal to align recording phases. Objective: This work's purpose is to develop an LAT mapping approach that does not rely on a time-alignment reference (TAR). Methods: To create an LAT map in absence of TAR (TARLess), the coordinates and LATs of recording electrodes are collected sequentially; a bank of candidate functions (CFs) is constructed that contains constant binary level CFs and non-linear functions of recording points' coordinates. Finally, a subset of CFs is linearly combined to create an activation time function with output matching electrodes' LATs. Synthetic and clinical data were deployed to validate TARLess. A simple two-dimensional computer model was used to create 30 different wavefront collision scenarios in a region with spatial conduction heterogeneities. Furthermore, sequential recordings were collected from seven atrial fibrillation patients during stimulation from one or two sites, after sinus rhythm was achieved post catheter ablation. Results: We showed that TARLess maps are similar to the one that uses TAR; for the 20 clinical maps, the mean absolute difference between measured LAT with the TAR and TARLess approach was $5.2 \pm 2.0$ milliseconds. Conclusion: We developed a novel method to create an LAT map of sequential recordings without using any TAR and showed that it can create accurate maps even during the collision of multiple wavefronts. Significance: TARLess mapping does not require a reference catheter which could lead to reduction in ablation procedure duration, cost, and potential complications.

  • Implantable Cardioverter-defibrillator Deactivation at Distance for the Dignity of Dying (the 4D Project)

    by Bryce Alexander, Melanie Foisy, Tereza Florica, Sanoj Chacko, Hoshiar Abdollah, Victor Neira, Andres Enriquez, Annie Hung, Damian P. Redfearn, Christopher S. Simpson, et al.


  • Impact of bundle branch block morphology on outcomes of patients with syncope and bifascicular block: A SPRITELY (POST 3) substudy

    by Victor Neira, Andres Enriquez, Robert Sheldon, Matthew G. Hanson, Connor Maxey, Adrian Baranchuk


  • Open Access

    Membrana de circulación extracorpórea veno-arterial para ablación de tormenta eléctrica en shock cardiogénico: caso clínico

    by Rodrigo Mella, Luis Quiñiñir, Víctor Neira, Juan Carlos Bahamondes, Rodrigo Miranda, Leandro Ortega, Ronald Trujillo

    Se presenta el caso clínico de un paciente que presenta un infarto del miocardio con trombolisis no exitosa y posterior implantación de 2 stents coronarios quien desarrolla, algunos días después, una tormenta eléctrica ventricular. Una ablación de la taquicardia se realizó bajo ECMO, con buen resultado. Se detalla la descripción del caso, revisa y discute el tema.

  • Open Access

    Evaluación de la anticoagulación con rivaroxaban, en pacientes con fibrilación auricular no valvular de reciente diagnóstico

    by Víctor Neira, Ramón Corbalán, Jaime Pereira, Olga Panes, Bernardita Garayar, Andrés Aizman, Silvana Llevaneras, Luis Villarroel

    Atrial fibrillation (AF) generates a hypercoagulable state with an increased thrombin generation and raised levels of thrombin-antithrombin complexes, which results in a high risk of stroke and thromboembolism. To evaluate the anticoagulant effect of rivaroxaban by anti-Xa factor activity and its correlation with thrombin-antithrombin complexes, thrombin generation and prothrombin time in patients newly diagnosed with non-valvular AF. Prospective study in patients with indication of anticoagulation. Demographic variables, cardiovascular risk factors, CHA2DS2-VASc and HAS-BLED scores were recorded. Blood samples were taken at baseline, at 3 and 24 hours after the administration of the drug and at 30 days. Rivaroxaban levels, anti-Xa activity, prothrombin time, thrombin generation and plasma levels of thrombin-antithrombin complexes were determined. We studied 20 patients aged 76.3 ± 8.0 years (60% female) with a CHA2DS2-VASc score > 2 points. The anti-Xa factor activity correlated with rivaroxaban plasma levels at 3 hours (r = 0.61, p < 0.01), at 24 hours (r = 0.85, p < 0.01) and at 30 days (r = 0.99, p < 0.01), with prothrombin time at 3 hours (r = -0.86, p = 0.019) and at 30 days (r = -0.63, p = 0.02) and with a sustained decrease in thrombin generation at 30 days of follow-up (r = -0.74, p < 0.01). There was no correlation with thrombin-antithrombin complexes (r = -0.02, p = 0.83). Rivaroxaban consistently inhibited the mild pro-coagulant state found in newly diagnosed non-valvular AF patients through the first 24 hours and this effect was maintained at 30 days. Plasma levels of the drug correlated with anti-Xa factor activity, thrombin generation and prothrombin time.

  • Open Access

    Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria

    by Víctor Neira V, Marcelo Potthoff N, Luis Quiñiñir S, Gabriel López R, Benjamín Stockins F, Carlos Castillo B, Fernando Lanas Z

    Background: Implementation of health programs to reduce cardiovascular risk, are needed for secondary prevention of cardiovascular diseases. Aim: To evalúate achievements of secondary prevention goals, pharmacologic prescription and major cardiovascular events in patients with coronary artery disease. Material and Methods: Patients who had a first event of acute coronary syndrome, angioplasty or revascularization surgery, between January 2008 and June 2010, were contacted for a clinical and laboratory evaluation between June and October 2011. Results: Seven hundred and two medical records were reviewed and 245 eligible patients were identified. Ofthese, we assessed 202 patients aged 64 ± 10 years (70% males). Sixty seven percent had two ormore cardiovascular riskfactors. A goal ofHDL cholesterol level over 40 mg/dL was achieved in 91 % of patients, smoking cessation in 84% and a total cholesterol < 200 mg/dL in 66%. A blood pressure below 130/85 mm Hgwas achieved in 30% of patients, a normal BMI in 19% and LDL cholesterol levels below 70 mg/dL in 18%. At the moment of assessment, 87%> were using aspirin, 78%> statins, 74% angiotensin converting enzyme inhibitors or angiotensin II receptor antagonists and 66%o were using β - blockers. Twenty two percent of patients had a major cardiovascular event during the follow up, which lasted 28 ± 8 months. Conclusions: A low percentage of cardiovascular goals achievement was observed in this sample of patients, with a high prevalence of overweight and obesity. A high percentage quit smoking after their first cardiovascular event. Despite the high percentage of drug prescription, hypertension and dyslipidemia were not fully controlled.